nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—FMO3—sweat—sclerosing cholangitis	0.41	0.522	CbGeAlD
Olanzapine—ORM1—bile—sclerosing cholangitis	0.134	0.171	CbGeAlD
Olanzapine—ORM1—gall bladder—sclerosing cholangitis	0.0372	0.0474	CbGeAlD
Olanzapine—ALB—gall bladder—sclerosing cholangitis	0.0326	0.0416	CbGeAlD
Olanzapine—H1F0—pancreas—sclerosing cholangitis	0.0201	0.0256	CbGeAlD
Olanzapine—FMO3—liver—sclerosing cholangitis	0.0174	0.0222	CbGeAlD
Olanzapine—HRH2—liver—sclerosing cholangitis	0.0155	0.0198	CbGeAlD
Olanzapine—HTR5A—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0139	0.0646	CbGpPWpGaD
Olanzapine—H1F0—liver—sclerosing cholangitis	0.0128	0.0163	CbGeAlD
Olanzapine—ADRA2C—pancreas—sclerosing cholangitis	0.0114	0.0145	CbGeAlD
Olanzapine—ORM1—liver—sclerosing cholangitis	0.0109	0.0139	CbGeAlD
Olanzapine—ALB—liver—sclerosing cholangitis	0.00957	0.0122	CbGeAlD
Olanzapine—ADRA2A—pancreas—sclerosing cholangitis	0.00909	0.0116	CbGeAlD
Olanzapine—HTR7—liver—sclerosing cholangitis	0.00789	0.01	CbGeAlD
Olanzapine—CYP2C19—liver—sclerosing cholangitis	0.0077	0.00981	CbGeAlD
Olanzapine—ADRA1A—liver—sclerosing cholangitis	0.00761	0.00969	CbGeAlD
Olanzapine—HTR1E—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00749	0.0349	CbGpPWpGaD
Olanzapine—ADRA2C—liver—sclerosing cholangitis	0.00725	0.00923	CbGeAlD
Olanzapine—HRH2—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00667	0.0311	CbGpPWpGaD
Olanzapine—DRD5—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00663	0.0309	CbGpPWpGaD
Olanzapine—CYP1A2—liver—sclerosing cholangitis	0.00629	0.00801	CbGeAlD
Olanzapine—CYP2C9—liver—sclerosing cholangitis	0.00597	0.00761	CbGeAlD
Olanzapine—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00571	0.0266	CbGpPWpGaD
Olanzapine—H1F0—Apoptosis—BCL2L11—sclerosing cholangitis	0.00528	0.0246	CbGpPWpGaD
Olanzapine—HTR6—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00512	0.0238	CbGpPWpGaD
Olanzapine—HTR7—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00511	0.0238	CbGpPWpGaD
Olanzapine—HTR1D—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00508	0.0236	CbGpPWpGaD
Olanzapine—ABCB1—pancreas—sclerosing cholangitis	0.00507	0.00645	CbGeAlD
Olanzapine—HTR1B—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00497	0.0232	CbGpPWpGaD
Olanzapine—HTR2A—liver—sclerosing cholangitis	0.00492	0.00626	CbGeAlD
Olanzapine—DRD4—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00489	0.0228	CbGpPWpGaD
Olanzapine—CHRM4—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00483	0.0225	CbGpPWpGaD
Olanzapine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00478	0.0223	CbGpPWpGaD
Olanzapine—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00469	0.0219	CbGpPWpGaD
Olanzapine—HTR2B—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00467	0.0218	CbGpPWpGaD
Olanzapine—CHRM5—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00462	0.0215	CbGpPWpGaD
Olanzapine—CYP3A4—liver—sclerosing cholangitis	0.00455	0.0058	CbGeAlD
Olanzapine—CYP2D6—liver—sclerosing cholangitis	0.00448	0.00571	CbGeAlD
Olanzapine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00447	0.0208	CbGpPWpGaD
Olanzapine—DRD1—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0044	0.0205	CbGpPWpGaD
Olanzapine—DRD3—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00434	0.0202	CbGpPWpGaD
Olanzapine—ADRA2B—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00392	0.0183	CbGpPWpGaD
Olanzapine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00382	0.0178	CbGpPWpGaD
Olanzapine—HTR1A—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00379	0.0176	CbGpPWpGaD
Olanzapine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00377	0.0175	CbGpPWpGaD
Olanzapine—ADRA2C—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00366	0.0171	CbGpPWpGaD
Olanzapine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00361	0.0168	CbGpPWpGaD
Olanzapine—DRD2—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00332	0.0155	CbGpPWpGaD
Olanzapine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00327	0.0152	CbGpPWpGaD
Olanzapine—HRH1—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00326	0.0152	CbGpPWpGaD
Olanzapine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00325	0.0152	CbGpPWpGaD
Olanzapine—CHRM3—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00324	0.0151	CbGpPWpGaD
Olanzapine—ABCB1—liver—sclerosing cholangitis	0.00322	0.00411	CbGeAlD
Olanzapine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00321	0.015	CbGpPWpGaD
Olanzapine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0032	0.0149	CbGpPWpGaD
Olanzapine—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.00298	0.0139	CbGpPWpGaD
Olanzapine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00295	0.0137	CbGpPWpGaD
Olanzapine—HTR3A—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00253	0.0118	CbGpPWpGaD
Olanzapine—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00249	0.0116	CbGpPWpGaD
Olanzapine—FMO3—Biological oxidations—GGT1—sclerosing cholangitis	0.00243	0.0113	CbGpPWpGaD
Olanzapine—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00192	0.00896	CbGpPWpGaD
Olanzapine—FMO3—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00183	0.00851	CbGpPWpGaD
Olanzapine—HTR3A—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00171	0.00795	CbGpPWpGaD
Olanzapine—CYP2C19—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00148	0.00687	CbGpPWpGaD
Olanzapine—H1F0—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00147	0.00683	CbGpPWpGaD
Olanzapine—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00135	0.00627	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00128	0.00596	CbGpPWpGaD
Olanzapine—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00115	0.00536	CbGpPWpGaD
Olanzapine—ALB—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00105	0.00487	CbGpPWpGaD
Olanzapine—FMO3—Metabolism—ABCB4—sclerosing cholangitis	0.00101	0.00472	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000845	0.00394	CbGpPWpGaD
Olanzapine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000802	0.00374	CbGpPWpGaD
Olanzapine—HTR7—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000744	0.00346	CbGpPWpGaD
Olanzapine—HTR1A—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.000742	0.00346	CbGpPWpGaD
Olanzapine—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.000731	0.00341	CbGpPWpGaD
Olanzapine—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00073	0.0034	CbGpPWpGaD
Olanzapine—DRD4—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000712	0.00332	CbGpPWpGaD
Olanzapine—ALB—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000681	0.00317	CbGpPWpGaD
Olanzapine—HTR2A—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.000641	0.00299	CbGpPWpGaD
Olanzapine—DRD1—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000641	0.00298	CbGpPWpGaD
Olanzapine—DRD3—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000632	0.00295	CbGpPWpGaD
Olanzapine—CHRM2—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.000629	0.00293	CbGpPWpGaD
Olanzapine—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000597	0.00278	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000573	0.00267	CbGpPWpGaD
Olanzapine—CYP2C19—Biological oxidations—GGT1—sclerosing cholangitis	0.000549	0.00256	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000524	0.00244	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000514	0.0024	CbGpPWpGaD
Olanzapine—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.000505	0.00235	CbGpPWpGaD
Olanzapine—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.000501	0.00233	CbGpPWpGaD
Olanzapine—DRD2—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000484	0.00225	CbGpPWpGaD
Olanzapine—FMO3—Metabolism—GOT2—sclerosing cholangitis	0.000481	0.00224	CbGpPWpGaD
Olanzapine—CHRM1—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000473	0.00221	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000469	0.00218	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000456	0.00212	CbGpPWpGaD
Olanzapine—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.000428	0.00199	CbGpPWpGaD
Olanzapine—FMO3—Metabolism—GOT1—sclerosing cholangitis	0.000415	0.00193	CbGpPWpGaD
Olanzapine—FMO3—Metabolism—GGT1—sclerosing cholangitis	0.000415	0.00193	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000406	0.00189	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000404	0.00188	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000401	0.00187	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—ABCB4—sclerosing cholangitis	0.000398	0.00185	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000359	0.00167	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—ABCB4—sclerosing cholangitis	0.000352	0.00164	CbGpPWpGaD
Olanzapine—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.00033	0.00154	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—ABCB4—sclerosing cholangitis	0.000323	0.00151	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000312	0.00145	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000311	0.00145	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000309	0.00144	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000303	0.00141	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000298	0.00139	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000294	0.00137	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000284	0.00133	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000281	0.00131	CbGpPWpGaD
Olanzapine—ADRA2B—Hemostasis—NOS2—sclerosing cholangitis	0.000273	0.00127	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000268	0.00125	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000265	0.00123	CbGpPWpGaD
Olanzapine—ALB—Metabolism—ABCB4—sclerosing cholangitis	0.000255	0.00119	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—NOS2—sclerosing cholangitis	0.000255	0.00119	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000239	0.00111	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000235	0.00109	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000231	0.00107	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000229	0.00107	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ABCB4—sclerosing cholangitis	0.000229	0.00107	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000224	0.00104	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000223	0.00104	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000223	0.00104	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00022	0.00102	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000211	0.000982	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.000211	0.000981	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.000209	0.000973	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—NOS2—sclerosing cholangitis	0.000207	0.000964	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000203	0.000943	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000199	0.000928	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000199	0.000926	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000198	0.000923	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000198	0.00092	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000196	0.000911	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000195	0.000909	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000194	0.000904	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000192	0.000896	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—GOT2—sclerosing cholangitis	0.000189	0.000881	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000181	0.000845	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000178	0.000831	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000173	0.000805	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000172	0.0008	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—GOT2—sclerosing cholangitis	0.000167	0.00078	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000164	0.000765	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—NOS2—sclerosing cholangitis	0.000163	0.000761	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—GGT1—sclerosing cholangitis	0.000163	0.00076	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—GOT1—sclerosing cholangitis	0.000163	0.00076	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—GOT2—sclerosing cholangitis	0.000154	0.000715	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—GOT1—sclerosing cholangitis	0.000144	0.000673	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—GGT1—sclerosing cholangitis	0.000144	0.000673	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000138	0.000642	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—GOT1—sclerosing cholangitis	0.000133	0.000618	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—GGT1—sclerosing cholangitis	0.000133	0.000618	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000133	0.000617	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000132	0.000617	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000132	0.000613	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000129	0.0006	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000127	0.00059	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000125	0.000582	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GOT2—sclerosing cholangitis	0.000121	0.000565	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000121	0.000564	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00012	0.000558	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000114	0.000532	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000113	0.000524	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GOT2—sclerosing cholangitis	0.000109	0.000507	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.000106	0.000495	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GGT1—sclerosing cholangitis	0.000105	0.000487	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GOT1—sclerosing cholangitis	0.000105	0.000487	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000102	0.000473	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	0.0001	0.000466	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	9.92e-05	0.000462	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—HIF1A—sclerosing cholangitis	9.81e-05	0.000457	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—HIF1A—sclerosing cholangitis	9.76e-05	0.000455	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HIF1A—sclerosing cholangitis	9.49e-05	0.000442	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GGT1—sclerosing cholangitis	9.39e-05	0.000437	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GOT1—sclerosing cholangitis	9.39e-05	0.000437	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HIF1A—sclerosing cholangitis	9.34e-05	0.000435	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GGT1—sclerosing cholangitis	9.17e-05	0.000427	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GOT1—sclerosing cholangitis	9.17e-05	0.000427	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	8.64e-05	0.000402	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	8.64e-05	0.000402	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HIF1A—sclerosing cholangitis	8.61e-05	0.000401	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	8.56e-05	0.000399	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	8.56e-05	0.000399	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	8.48e-05	0.000395	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—HIF1A—sclerosing cholangitis	8.48e-05	0.000395	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HIF1A—sclerosing cholangitis	8.46e-05	0.000394	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HIF1A—sclerosing cholangitis	8.43e-05	0.000393	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HIF1A—sclerosing cholangitis	8.4e-05	0.000392	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HIF1A—sclerosing cholangitis	8.32e-05	0.000388	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HIF1A—sclerosing cholangitis	8.3e-05	0.000387	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HIF1A—sclerosing cholangitis	7.71e-05	0.000359	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	7.32e-05	0.000341	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	7.32e-05	0.000341	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	6.54e-05	0.000305	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	5.65e-05	0.000263	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	5.65e-05	0.000263	CbGpPWpGaD
